How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Apex BioTechnology Corp. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
35 clearance records and 0 recall records in the covered releases, across 1 source company names and 5 product codes. Dated history runs from Jan 22, 2001 to Apr 4, 2025.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| UASure II Blood Uric Acid Monitoring SystemK242209 · PTC | Apex BioTechnology Corp. | 510(k) | Apr 4, 2025FDA decision date |
| GlucoSure ADVANCE Link Blood Glucose Monitoring SystemK222234 · NBW | Apex BioTechnology Corp. | 510(k) | Dec 21, 2022FDA decision date |
| BGM039 Blood Glucose Monitoring System, BGM039 Link Blood Glucose Monitoring SystemK220421 · NBW | Apex BioTechnology Corp. | 510(k) | Nov 4, 2022FDA decision date |
| GlucoSure Link Blood Glucose Monitoring SystemK212140 · NBW | Apex BioTechnology Corp. | 510(k) | Aug 25, 2022FDA decision date |
| MTM301 Blood Glucose and Ketone Monitoring SystemK202534 · NBW | Apex BioTechnology Corp. | 510(k) | Apr 6, 2022FDA decision date |
| GAL-1A Plus Blood Glucose Monitoring SystemK213887 · NBW | Apex BioTechnology Corp. | 510(k) | Mar 29, 2022FDA decision date |
| MultiSure GK Link Blood Glucose and Ketone Monitoring SystemK201880 · NBW | Apex BioTechnology Corp. | 510(k) | Oct 15, 2021FDA decision date |
| GlucoSure HT Plus Blood Glucose Monitoring SystemK202885 · NBW | Apex BioTechnology Corp. | 510(k) | Sep 15, 2021FDA decision date |
| KET-1 Blood Ketone Monitoring SystemK182593 · JIN | Apex BioTechnology Corp. | 510(k) | Dec 18, 2018FDA decision date |
| BGM014 Blood Glucose Monitoring SystemK182992 · NBW | Apex BioTechnology Corp. | 510(k) | Nov 28, 2018FDA decision date |
| BGM009 Plus Blood Glucose Monitoring SystemK170267 · NBW | Apex BioTechnology Corp. | 510(k) | Mar 9, 2017FDA decision date |
| BGM014 Blood Glucose Monitoring System, BGM014 Pro Blood Glucose Monitoring SystemK161299 · NBW | Apex BioTechnology Corp. | 510(k) | Dec 23, 2016FDA decision date |
| Autosure Voice II Blood Glucose Monitoring System, Autosure Voice II Pro Blood Glucose Monitoring System, Autosure Blood Glucose Test Strips, Aut…K150396 · NBW | Apex BioTechnology Corp. | 510(k) | Oct 14, 2015FDA decision date |
| GAL-1F Blood Glucose Monitoring System, GAL-1F Pro Blood Glucose Monitoring SystemK142689 · CGA | Apex BioTechnology Corp. | 510(k) | Aug 6, 2015FDA decision date |
| MEG-2B Blood Glucose Monitoring System, MEG-2B Pro Blood Glucose Monitoring SystemK143750 · CGA | Apex BioTechnology Corp. | 510(k) | May 7, 2015FDA decision date |
| BGM009 BLOOD GLUCOSE MONITORING SYSTEMK141036 · NBW | Apex BioTechnology Corp. | 510(k) | May 1, 2015FDA decision date |
| AUTOSURE HT BLOOD GLUCOSE MONITORING SYSTEMK131750 · CGA | Apex BioTechnology Corp. | 510(k) | Mar 6, 2014FDA decision date |
| AUTOSURE VOICE 3 PLUS BLOOD GLUCOSE MONITORING SYSTEMK120649 · NBW | Apex BioTechnology Corp. | 510(k) | Jul 6, 2012FDA decision date |
| MEG-2B BLOOD GLUCOSE MONITORING SYSTEM, PRO BLOOD GLUCOSE MONITORING SYSTEM, BLOOD GLUCOSE TEST STRIPS, GLUCOSE CONTROLK120448 · CGA | Apex BioTechnology Corp. | 510(k) | Apr 6, 2012FDA decision date |
| GAL-1E BLOOD GLUCOSE MONITORING SYSTEM GAL-1E BLOOD GLUCOSE TEST STRIPS GAL-1E MULTI BLOOD GLUCOSE MONITORING SYSTEM GALK113547 · CGA | Apex BioTechnology Corp. | 510(k) | Mar 28, 2012FDA decision date |
| GAL-1A BLOOD GLUCOSE MONITORING SYSTEMK113208 · CGA | Apex BioTechnology Corp. | 510(k) | Jan 26, 2012FDA decision date |
| AUTOSURE VOICE II PLUS, AUTOSURE PLUS BLOOD GLUCOSE TEST STRIPS,CONTREX PLUS IIIK113098 · NBW | Apex BioTechnology Corp. | 510(k) | Jan 17, 2012FDA decision date |
| GAL-1C BLOOD GLUCOSE MONITORING SYSTEM, GAL-1C TEST STRIPSK102816 · NBW | Apex BioTechnology Corp. | 510(k) | Sep 15, 2011FDA decision date |
| MEG-2 BLOOD GLUCOSE MONITORING SYSTEM, MEG-2 50'S TEST STRIP, MEG-2 CONTROL SOLUTIONK101204 · CGA | Apex BioTechnology Corp. | 510(k) | Aug 31, 2011FDA decision date |
| AUTOSURE VOICE 3 BLOOD GLUCOSE MONITORING SYSTEM AND TEST STRIPK102481 · NBW | Apex BioTechnology Corp. | 510(k) | Apr 28, 2011FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.